REG - ASB Bank Limited - ASB EMTN Programme Circular dated 30 June 2022

Commonwealth Bank of AustraliaAnnouncement

01/07/2022 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220701:nRSA9322Qa&default-theme=true

RNS Number : 9322Q  ASB Bank Limited  01 July 2022

ASB Bank Limited

1 July 2022

Publication of a Prospectus

The following Prospectus has been approved by the FCA and is available for
viewing:

ASB Programme Circular dated 30 June 2022 for the U.S.$70,000,000,000 Euro
Medium Term Note Programme between ASB Bank Limited, ASB Finance Limited and
Commonwealth Bank of Australia

To view the full document, please paste the following URL into the address bar
of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/9322Q_1-2022-7-1.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/9322Q_1-2022-7-1.pdf)

A copy of this document has been submitted to the National Storage Mechanism
and will be available for inspection shortly.

Please see: https://www.asb.co.nz/legal/emtn-programme.html for further
information.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus may be addressed
to and/or targeted at persons who are residents of particular countries
(specified in the relevant Prospectus) only and is not intended for use and
should not be relied upon by any person outside these countries and/or to whom
the offer contained in the relevant Prospectus is not addressed. Prior to
relying on the information contained in the relevant Prospectus you must
ascertain from the relevant Prospectus whether or not you are part of the
intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above
requirement.

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PDIBKDBPDBKKQOK